Women who breastfeed develop protective immune cells that help guard against breast cancer, with effects lasting for more than 30 years, new research shows. The study...
Co-written By Dr Claire Gillvray and Tarang Majmudar, Welbeck Cambridge (2026) Gynaecological cancers, cervical, ovarian, uterine, vaginal, and vulvar, pose a significant health risk across all...
Whole genome sequencing could identify unique genetic features to guide treatment for more than 15,000 breast cancer patients each year in the UK, new research suggests....
A targeted therapy has improved survival compared with chemotherapy in patients with triple-negative breast cancer who cannot receive immunotherapy. The drug, an antibody-drug conjugate (a treatment...
High-risk women can now delay ovary removal surgery through NHS screening, helping them preserve fertility and avoid early surgical menopause. The ROCA test tracks women with...
A large, long-term study has found that the introduction of the human papillomavirus (HPV) vaccine in community settings is highly effective in protecting young women from...
AbbVie said on Monday that it will launch ovarian cancer drug Elahere in the UK at the same list price as in the US. The announcement...
GENinCode shares rose 6 per cent on Thursday after University College London Hospitals (UCLH) became the first NHS trust to introduce its ovarian cancer test. The...
New research has identified a genomic signature that makes it possible to anticipate which patients with HR+/HER2- breast cancer will respond less well to CDK4/6 inhibitors. ...
Women who miss their first mammogram face a 40 per cent higher risk of dying from breast cancer over 25 years, mainly because cancers are detected...
